CLS
Showing 1 - 25 of 226
Amyotrophic Lateral Sclerosis Trial (ABBV-CLS-7262 Dose 1, ABBV-CLS-7262 Dose 2, Matching Placebo)
Not yet recruiting
- Amyotrophic Lateral Sclerosis
- ABBV-CLS-7262 Dose 1
- +2 more
- (no location specified)
Feb 12, 2023
Neovascular Age-related Macular Degeneration Trial in Phoenix (CLS-AX, Aflibercept)
Recruiting
- Neovascular Age-related Macular Degeneration
-
Phoenix, ArizonaRetinal Research Institute, LLC
Jun 4, 2023
Vanishing White Matter Disease Trial in Salt Lake City (ABBV-CLS-7262)
Recruiting
- Vanishing White Matter Disease
-
Salt Lake City, UtahUniversity of Utah Hospital
Mar 6, 2023
Long-term Outcomes of Subjects in the CLS-AX CLS1002-101 Study
Active, not recruiting
- Neovascular Age-related Macular Degeneration
-
Phoenix, Arizona
- +6 more
Dec 14, 2022
Syncope, Syncope, Vasovagal Trial in Bolzano, Napoli
Completed
- Syncope
- Syncope, Vasovagal
-
Bolzano, Italy
- +1 more
Sep 15, 2023
ALS, Amyotrophic Lateral Sclerosis Trial in Canada, United States (ABBV-CLS-7262, Placebo)
Active, not recruiting
- ALS
- Amyotrophic Lateral Sclerosis
- ABBV-CLS-7262
- Placebo
-
Irvine, California
- +13 more
Jan 20, 2023
ADHD Trial in San Francisco (CLS-R)
Terminated
- ADHD
- CLS-R
-
San Francisco, California
- +1 more
Jan 26, 2023
Open Angle Glaucoma Trial in Geneva (contact lens sensor (CLS) SENSIMED Triggerfish®)
Terminated
- Open Angle Glaucoma
- contact lens sensor (CLS) SENSIMED Triggerfish®
-
Geneva, SwitzerlandUniversity Hospital Geneva
May 16, 2023
Superficial Esophageal Cancer Trial in Okayama (CLS2702C/CLS2702D)
Recruiting
- Superficial Esophageal Cancer
- CLS2702C/CLS2702D
-
Okayama, JapanOkayama University Hospital
Jul 29, 2021
Heart Failure, ICD, Chronotropic Incompetence Trial in La Jolla (CLS Mode on Biotronik CRT-D, Accelerometer Mode on Biotronik
Completed
- Heart Failure
- +2 more
- CLS Mode on Biotronik CRT-D
- Accelerometer Mode on Biotronik CRT-D
-
La Jolla, CaliforniaSulpizio Cardiovascular Center
Jul 14, 2021
ADHD, Oppositional Defiant Disorder Trial in San Francisco (CLS-R-FUERTE)
Not yet recruiting
- ADHD
- Oppositional Defiant Disorder
- CLS-R-FUERTE
-
San Francisco, CaliforniaUCSF
Aug 8, 2022
ADHD Trial in San Francisco (CaregiverAssist)
Enrolling by invitation
- Attention Deficit Hyperactivity Disorder
- CaregiverAssist
- Behavioral Parent Training (CLS Parent Group)
-
San Francisco, CaliforniaHALP Clinic, Children's Center at Langley Porter, UCSF
Oct 31, 2022
ADHD Trial (CLS-FUERTE)
Completed
- ADHD
- CLS-FUERTE
- (no location specified)
Oct 5, 2021
Overall Skin Appearance, Dry Skin; Eczema Trial in Sarajevo (Cosmetic Active Ingredient CLS02021, Placebo PLC01021)
Completed
- Overall Skin Appearance
- Dry Skin; Eczema
- Cosmetic Active Ingredient CLS02021
- Placebo PLC01021
-
Sarajevo, Bosnia and Herzegovina
- +1 more
Sep 23, 2021
Diabetic Macular Edema Trial in Mountain View, The Woodlands (IVT Aflibercept, SC CLS-TA)
Completed
- Diabetic Macular Edema
- IVT Aflibercept
- SC CLS-TA
-
Mountain View, California
- +1 more
Apr 22, 2021
ADHD, Oppositional Defiant Disorder Trial in San Francisco (CLS-R-FUERTE)
Recruiting
- ADHD
- Oppositional Defiant Disorder
- CLS-R-FUERTE
-
San Francisco, CaliforniaUCSF
Jun 15, 2022
Tumors, Kidney Tumors, Urologic Tumors Trial in Nanjing (Toripalimab, Axitinib, Lenvatinib)
Recruiting
- Neoplasms
- +12 more
- Toripalimab
- +3 more
-
Nanjing, Jiangsu, ChinaJinling Hospital, Affiliated Hospital of Medical School, Nanjing
Oct 28, 2023
Syncope Trial in Medellin, Medellín (Pacemaker with Closed Loop Stimulation (CLS))
Completed
- Syncope
- Pacemaker with Closed Loop Stimulation (CLS)
-
Medellin, Antioquia, Colombia
- +1 more
Mar 7, 2022
Surgery Trial in Fuzhou (single-incision plus one-port laparoscopic surgery, conventional laparoscopic surgery)
Recruiting
- Surgery
- single-incision plus one-port laparoscopic surgery
- conventional laparoscopic surgery
-
Fuzhou, Fujian, ChinaFujian Cancer Hospital
Oct 4, 2021
PMCF Study of the CLS Brevius Stem With Kinectiv Technology
Terminated
- Osteoarthritis
- +4 more
- CLS Brevius stem with Kinectiv technology
-
Bologna, Italy
- +3 more
Dec 14, 2020